4//SEC Filing
Meyers James R 4
Accession 0001209191-21-015508
CIK 0001001233other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:01 PM ET
Size
8.8 KB
Accession
0001209191-21-015508
Insider Transaction Report
Form 4
Meyers James R
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-02-25+16,400→ 16,400 totalExercise: $11.19Exp: 2031-02-24→ Common Stock (16,400 underlying) - Award
Common Stock
2021-02-25+8,200→ 23,200 total
Footnotes (3)
- [F1]Represents shares of common stock issuable upon settlement of restricted stock units ("RSUs"). The RSUs will fully vest on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP, as amended")), through such date and subject to acceleration as provided in the 2018 EIP, as amended.
- [F2]Includes: (a) 3,333 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on November 22, 2019 representing two remaining vesting tranches from such RSU grant with such RSUs vesting with respect to 1,666 shares on November 22, 2021 and 1,667 shares on November 22, 2022; and (b) 10,000 shares of common stock issuable upon settlement of RSUs subject to Reporting Person's May 18, 2020 RSU grant that will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the Issuer's 2021 annual stockholders meeting. The vesting of all such RSUs is subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended.
- [F3]Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP, as amended). The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Continuous Service (as defined in the 2018 EIP, as amended) over the 12-month period measured from the grant date and subject to acceleration as provided in the 2018 EIP, as amended.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001387521
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 9:01 PM ET
- Size
- 8.8 KB